Wealthstar Advisors LLC Buys Shares of 1,169 Eli Lilly and Company $LLY

robot
Abstract generation in progress

Wealthstar Advisors LLC initiated a new position in Eli Lilly and Company (NYSE:LLY) by purchasing 1,169 shares valued at approximately $1.256 million during Q4. Eli Lilly reported strong Q1 results, beating revenue and EPS estimates, and subsequently raised its full-year 2026 guidance, driven by the success of its GLP-1 drugs and potential favorable regulatory actions. The stock maintains a “Moderate Buy” consensus rating from analysts with an average target price near $1,218.93, reflecting continued institutional interest despite ongoing valuation debates and competitive risks.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin